Meet Our Team

Doug Ball

Doug Ball
CEO

Doug Ball

Doug previously founded a diagnostic company in the cardiac biomarker field and led its NASDAQ (and TSE) IPOs in the mid-1990s. He founded a second diagnostic startup in 2002 which was sold in 2015 to a US VC backed diagnostic company. He is a former management consultant, corporate banker and an experienced angel investor.

Patricia Lorenz

Patricia Lorenz
COO

CA, CGMA, CPA, DVM, MBA

Patricia Lorenz

Patricia Lorenz has served on the board of the Network of Angel Organizations - Ontario since 2008, has been a director of Agricorp, since 2013 and is a former director of NACO. She has had previous senior level operating and financial experience in the software, food processing, consumer products distribution, diagnostics and publishing industries and has run a university patenting and licensing office. Patricia is also an experienced angel investor.

Alex Ni

Alex Ni
CTO

CMA, CPA, MBA

Alex Ni

Alex Ni, is an accomplished senior technologist having completed a broad range of projects designing and implementing enterprise information systems in the spaces of telecommunication, digital media and consumer products, Alex brings 10+ years of solutions architecture experience to the Avertus leadership team, with particular expertise in digital rights management and security, as well as encryption with both hardware and software companies. Alex completed his MBA at Wilfrid Laurier University specializing in management accounting, and holds a CPA, CMA designation.

Peter Carlen

Peter Carlen
CSO

MD, FRCPC

Peter Carlen

Peter Carlen is a Professor of Medicine (Neurology), Physiology, and Institute of Biomaterials and Biomedical Engineering at the University of Toronto. He is a clinician/scientist, specializing in epilepsy and neurodegenerative diseases at the Toronto Western Hospital of the University Health Network. He has over 250 peer-reviewed biomedical publications and 6 patents. His main research interests are mechanisms of neural synchrony and entrainment in the context of epilepsy, fetal alcohol syndrome, hypoglycemic seizures, and neurodegenerative processes.

Berj Bardakjian

Berj L. Bardakjian
CAE

PhD, MD, FRCPC

Berj Bardakjian

Berj Bardakjian is a Professor in the Department of Electrical and Computer Engineering, the Institute of Biomaterials and Biomedical Engineering, and the Neuroscience Program (UTNP), at the University of Toronto. His research deals with the electrical phenomena in the brain. In particular, analysis and modelling of the brain's electrical rhythms to classify brain states, enhance the "desired" ones and abolish the "undesired" ones using cognitive devices. Application areas include epilepsy, consciousness and learning.

Cameron Macgregor

Cameron MacGregor
Biomedical Electronics Engineer

BEng, MHSc

Cameron MacGregor

Cameron is a clinical engineering MHSc student at the Institute of Biomaterials and Biomedical Engineering at the University of Toronto and is spending the internship component of his program at Avertus. He holds a bachelor's degree in electrical engineering from the University of Manitoba.

Brandon Ro

Brandon Ro
Business Development

BSc, MMI

Brandon Ro

Brandon is a recent graduate of the Masters of Management program at the University of Toronto and has received a medical science degree from Western University. Brandon has 3 years of clinical research experience as well as experience co-running a technology start-up. He has a strong interest in business strategy and biotechnology.

Kevin Ardian

Kevin Ardian
Biomedical Engineer

BEng, MEng

Kevin Ardian

Kevin is an electrical and biomedical engineer. He is skilled at the area of biosignal processing and machine learning, as well as medical equipment regulation and standards. He recently finished his MEng degree in Biomedical Engineering at University of Toronto with a focus on the design and commercialization of biomedical devices. He also holds a BEng (Hons) degree in Electrical Engineering from National University of Singapore, specializing in computational sensory systems.

Evan Shang

Dano Morrison
Biomedical Application Developer

BSc, MSc

Dano Morrison

Dano holds a MSc. in neurophysiology from the University of Toronto and is a self-taught web and mobile developer. After 7 years in the lab, Dano decided to shift his focus to the emerging world of neurotechnology and built EEG 101, an open-source neuroscience tutorial for Android that uses real-time EEG data. At Avertus, he's thrilled to be building software that unites his love of the brain, machine learning, and the web.

Contact Us

About Us

Avertus is a Canadian neurotechnology company comprised of experienced business professionals, visionary academics, technological experts, and a talented engineering team.  Our core competencies are in the areas of development, manufacturing, and commercialization of superior grade biomedical devices.


We have developed an easy-to-use, artifact-movement-reducing, dry electrode EEG headset coupled with a cloud system. The headset has been designed as a simple portable EEG monitor for a broad range of applications in the research market. It will soon advance to a medical grade monitor akin to an ambulatory EEG "Holter" monitor for use in clinics and home settings. Our development team is working on our proprietary seizure and brain state detection algorithms for use with the headset.


Our Mission

Design, produce and support headsets for neurologists and clinical technicians to lower overall health care cost for treating neurological related diseases.